News

30.04.12 Le "Facebook" du montagnard

Quelque 13 300 sommets et 23 200 itinéraires sont aujourd'hui répertoriés par Camptocamp, start-up du Parc scientifique d'Ecublens

27.04.12 Abionic lève 2 millions de francs

La spin-off de l'EPFL active dans la détection des allergies, a été sélectionnée hier par Red Herring parmi les 100 entreprises les plus innovantes d'Europe et vient d'obtenir deux millions de fonds d'investisseurs privés et institutionnels

25.04.12 EPFL / PSE start-ups in the press

PME magazine consacre de nombreuses pages aux start-up de l'EPFL et du Parc Scientifique d'Ecublens

24.04.12 routeRANK wins the 'Sustainable Entrepreneurship Award'

The SEA Awards is an international award that honours sustainable entrepreneurial activities

18.04.12 Des start-up qui comptent!

Kandou et Aleva Neurotherapeutics deux start-up installées au parc scientifique de l'EPFL ont levé, à elles deux, 14 millions de francs

17.04.12 "Un vaccin contre la maladie d'Alzheimer, le rêve de ma vie"

AC Immune, entreprise implantée au PSE poursuit des recherches pour aboutir à un vaccin contre la maladie d'Alzheimer

11.04.12 Ten million to lower energy consumption…

Kandou, the start-up working on lowering the energy consumption of electronic devices, has obtained financing of 10 million Swiss Francs for its innovation, we learn in Bilan… Read more:Bilan - Kandou lève 10 millions

11.04.12 ...and 4 Million for Aleva Neurotherapeutics

The spin-off Aleva Neurotherapeutics from the EPFL has finalized another round of financing

11.04.12 Gene Signal: treating macular degeneration

Another EPFL spin-off, Gene Signal, has developed a promising treatment for macular degeneration that is less expensive than what is currently proposed by the large pharmaceutical companies

10.04.12 Aleva Neurotherapeutics raises 4 million Swiss Francs

Principal investor Banexi Ventures Partners joins a solid investment consortium Lausanne, Switzerland, 10 April 2012 Aleva Neurotherapeutics, developer of next generation implants for deep brain stimulation (DBS) therapy for major neurol

10.04.12 Crisalix: Mirror, mirror, on the wall…

A new application makes it possible for cosmetic surgeons to show their patients an extremely realistic 3D image of results in advance of an operation

27.03.12 Gene Signal – the New Generation Angiogenesis based medicine

Gene Signal is a start-up based in EPFL’s PSE

26.03.12 Candidates for the PERL Award

Five EPFL spin-offs are mentioned in two editions of 24 Heures (19 and 26 March)

26.03.12 Aleva’s Executive Committee reorganizes

Two new persons have joined the Board of Directors of Aleva Neurotherapeutics

14.03.12 NEXThink Raises $5.5M From Auriga, Venture Incubator, Mannai

NEXThink said it raised $5

13.03.12 Kandou raises S10M Series A funds

The PSE start-up Kandou has just raised $10 million

06.03.12 nViso’s useful marketing research tool

Since 2010, the start-up nViso from the EPFL’s PSE has marketed a computer program to detect and recognize facial expressions

28.02.12 nViso announced they are working with IBM

nViso, a leading provider of emotion recognition software, today announced they are working with IBM to help the Swiss LINK Institute gauge emotional reactions of consumers to online advertisements and media

27.02.12 Solar Impulse: Three days in the cockpit

André Borschberg, the pilot of Solar Impulse, voluntarily spent 72 hours in the cockpit of the future HB-SIB plane

20.02.12 Everyone can be an editor with Paper.li and Newsmix

Paper